Poolbeg Pharma (POLB) Competitors GBX 3.30 -0.20 (-5.69%) As of 11:48 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesBuy This Stock POLB vs. MPH, OBI, ORPH, HEMO, IMM, REDX, ETX, HVO, SBTX, and COSShould you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include Mereo BioPharma Group plc (MPH.L) (MPH), Ondine Biomedical (OBI), Open Orphan (ORPH), Hemogenyx Pharmaceuticals (HEMO), ImmuPharma (IMM), Redx Pharma (REDX), e-therapeutics (ETX), hVIVO (HVO), SkinBioTherapeutics (SBTX), and Collagen Solutions plc (COS.L) (COS). These companies are all part of the "biotechnology" industry. Poolbeg Pharma vs. Its Competitors Mereo BioPharma Group plc (MPH.L) Ondine Biomedical Open Orphan Hemogenyx Pharmaceuticals ImmuPharma Redx Pharma e-therapeutics hVIVO SkinBioTherapeutics Collagen Solutions plc (COS.L) Mereo BioPharma Group plc (MPH.L) (LON:MPH) and Poolbeg Pharma (LON:POLB) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, media sentiment, valuation, risk, institutional ownership, profitability, analyst recommendations and dividends. Is MPH or POLB more profitable? Mereo BioPharma Group plc (MPH.L)'s return on equity of 0.00% beat Poolbeg Pharma's return on equity.Company Net Margins Return on Equity Return on Assets Mereo BioPharma Group plc (MPH.L)N/A N/A N/A Poolbeg Pharma N/A -32.56%-21.33% Which has stronger valuation and earnings, MPH or POLB? Poolbeg Pharma is trading at a lower price-to-earnings ratio than Mereo BioPharma Group plc (MPH.L), indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMereo BioPharma Group plc (MPH.L)N/AN/AN/A-£128.00N/APoolbeg PharmaN/AN/A-£4.50B-£1.14-2.89 Does the media favor MPH or POLB? In the previous week, Mereo BioPharma Group plc (MPH.L)'s average media sentiment score of 0.00 equaled Poolbeg Pharma'saverage media sentiment score. Company Overall Sentiment Mereo BioPharma Group plc (MPH.L) Neutral Poolbeg Pharma Neutral Do institutionals & insiders hold more shares of MPH or POLB? 1.5% of Poolbeg Pharma shares are owned by institutional investors. 7.6% of Poolbeg Pharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. SummaryMereo BioPharma Group plc (MPH.L) and Poolbeg Pharma tied by winning 3 of the 6 factors compared between the two stocks. Get Poolbeg Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding POLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart POLB vs. The Competition Export to ExcelMetricPoolbeg PharmaBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£23.01M£218.47M£6.17B£2.57BDividend YieldN/A3.80%5.72%5.38%P/E Ratio-2.893.3029.47500.32Price / SalesN/A5,568.90587.7798,879.50Price / Cash2.1113.1925.8227.90Price / Book0.0097.7912.448.11Net Income-£4.50B-£90.99M£3.32B£5.89B7 Day Performance-8.33%1.60%2.15%-0.58%1 Month Performance-16.05%5.15%8.41%0.81%1 Year Performance-60.24%574.07%61.67%130.23% Poolbeg Pharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)POLBPoolbeg PharmaN/AGBX 3.30-5.7%N/A-57.8%£23.01MN/A-2.8912MPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownOBIOndine BiomedicalN/AC$13.50-1.8%N/A+96.2%C$71.28MC$2.05M-192.86N/AORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179HEMOHemogenyx PharmaceuticalsN/AGBX 1,140-3.2%N/A+68,503.8%£63.13MN/A-493.6814Gap DownIMMImmuPharmaN/AGBX 11.10-7.5%N/A+551.2%£60.33MN/A-1,247.1913REDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading VolumeETXe-therapeuticsN/AN/AN/AN/A£52.59M£295K-450.0035High Trading VolumeHVOhVIVO3.0746 of 5 starsGBX 6.90+6.2%GBX 23+233.3%-74.5%£44.67M£51.28M896.10N/AHigh Trading VolumeSBTXSkinBioTherapeuticsN/AGBX 14.80+2.1%N/A-5.5%£37.52M£2.68M-1,184.0011Gap UpCOSCollagen Solutions plc (COS.L)N/AN/AN/AN/A£30.99M£4.01M-8.283,350 Related Companies and Tools Related Companies MPH Competitors OBI Competitors ORPH Competitors HEMO Competitors IMM Competitors REDX Competitors ETX Competitors HVO Competitors SBTX Competitors COS Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:POLB) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | Sponsored"I'm risking my reputation on this"The Fed rate cut truth they don't want you to know The Fed's 25 basis point cut isn't just monetary policy…...Crypto 101 Media | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredGOLD ALERTGold has shattered records, soaring past $3,800 an ounce... But Stansberry Senior Partner Dr. David "Doc" E...Stansberry Research | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Poolbeg Pharma PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Poolbeg Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
